Interval observers design for systems with ostensible Metzler system matrices
Frontiers in Aerospace Engineering · 2023
DOI: 10.3389/fpace.2023.1158718 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Aerospace Engineering, 2023. Verfasst von Dušan Krokavec und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper attempts to resolve the problem concerning the interval observers design for linear systems with ostensible Metzler system matrices. Because system dynamics matrices are partially different from strictly Metzler structures, a solution is achieved by constructing a composed system matrix representation, which combines pre-compensated interval matrix structures fixed with a prescribed region of D-stability and the reconstructed strictly Metzler matrix structure, related to the original interval system matrix parameter definition. A novel design procedure is presented, which results in a strictly positive observer gain matrix and guarantees that the lower estimates of the positive state variables are non-negative when considering the given system structure and the non-negative system state initial values. The design is computationally simple since it is reduced to the feasibility of the set of linear matrix inequalities.
Zitieren
APA
Krokavec, D., & Filasová, A. (2023). Interval observers design for systems with ostensible Metzler system matrices. Frontiers in Aerospace Engineering. https://doi.org/10.3389/fpace.2023.1158718
Vancouver
Krokavec D, Filasová A. Interval observers design for systems with ostensible Metzler system matrices. Frontiers in Aerospace Engineering. 2023. doi:10.3389/fpace.2023.1158718
BibTeX
@article{Krokavec2023,
author = {Krokavec, Dušan and Filasová, Anna},
title = {Interval observers design for systems with ostensible Metzler system matrices},
journal = {Frontiers in Aerospace Engineering},
year = {2023},
doi = {10.3389/fpace.2023.1158718}
}
EUVIMED